Morning Trend | JILIN CHANGLONG's main force tests again, is a medium-term swing opportunity emerging?

JILIN CHANGLONG experienced moderate volume increase yesterday, with the pharmaceutical sector's stable style favored by funds in a volatile market. Funds gradually flowed back within three days, and the stock price returned above the 30-day moving average, indicating a noticeable warming of the short-term bullish atmosphere. Discussions in the community about the defensive attributes of pharmaceuticals have increased, with risk-averse funds continuing to position themselves. Favorable industry policies are frequently emerging, with dynamics such as medical insurance negotiations and innovative drug access supporting industry sentiment. The company's news front is stable, with light pressure for positioning at low levels. The market shows that defensive attributes have been activated, and short-term elasticity has strengthened due to increased funds. Technical wave signals are gradually being established, but continuity will depend on the sector's heat and volume expansion. If there is a surge during the session that is met with profit-taking by the main force or weakened trading volume, it may easily fall into consolidation and fluctuation. There is still a risk of pullback when chasing short-term gains, and wave opportunities need to closely monitor the sustainability of funds. The overall strategy should focus on steady progress, with stop-loss measures in place and a priority on gradual low absorption